ReachMD

Be part of the knowledge.™

Global Heart Failure Academy

Leading global experts have combined guideline recommendations and new clinical data with practical, case-based formats that approximate clinical reality to improve patient outcomes in the management of heart failure. This series is focused on changing clinical behavior in the recognition and diagnoses of hyperkalemia and iron deficiency in heart failure, through the application of emerging science into everyday practice.

To return to the Global Heart Failure Academy, please click here.

This educational series is developed by Medtelligence. Supported by an unrestricted educational grant from Vifor Pharma.

68

LikeLikedUnlike

Episodes 1-15 of 17

- Peter van der Meer, MD, PhD
  Peer
- Pieter Martens, MD, PhD
  Peer
1
CME/CE
New Perspectives on the Management of HFrEF: Iron Deficiency and Cardiac Remodeling
New Perspectives on the Management of HFrEF: Iron Deficiency and Cardiac Remodeling
0.25 credits
- Ileana L. Piña, MD, MPH, FAHA, FACC
  Peer
- Javed Butler, MD, MBA, MPH
  Peer
- Marco Metra, MD
  Peer
- Giuseppe M.C. Rosano, MD, PhD, FESC, FHFA
  Peer
2
CME/CE
The Future of Heart Failure Management: Rethinking Approaches to Care
The Future of Heart Failure Management: Rethinking Approaches to Care
0.50 credits
- Javed Butler, MD, MBA, MPH
  Peer
- Piotr Ponikowski, MD, PHD, FESC, FHFA
  Peer
1
Global Heart Failure Academy
Clinical Implications of ESC/HFA Guideline Updates for Iron Deficiency in Heart Failure
Clinical Implications of ESC/HFA Guideline Updates for Iron Deficiency in Heart Failure
- Gregg C. Fonarow, MD
  Peer
- Andrew J. S. Coats, MD
  Peer
1
CME/CE
Applying Key Updates from ESC/HFA to Managing Heart Failure
Applying Key Updates from ESC/HFA to Managing Heart Failure
0.25 credits
- Keith C. Ferdinand, MD
  Peer
- Marco Metra, MD
  Peer
6
CME/CE
Managing HK in HF: Navigating the Evolving Clinical Landscape
Managing HK in HF: Navigating the Evolving Clinical Landscape
0.25 credits
- Mikhail Kosiborod, MD
  Peer
- Ewa A. Jankowska, MD, PhD, FESC
  Peer
- Phil McEwan, PhD
  Peer
1
CME/CE
Making the Case for Iron Replacement Therapy in HFrEF: Clinical and Pharmacoeconomic Impact
Making the Case for Iron Replacement Therapy in HFrEF: Clinical and Pharmacoeconomic Impact
0.25 credits
- Ileana L. Piña, MD, MPH, FAHA, FACC
  Peer
- Javed Butler, MD, MBA, MPH
  Peer
- Giuseppe M.C. Rosano, MD, PhD, FESC, FHFA
  Peer
2
CME/CE
From Guidelines to Practice: Key Updates From 2021 HFSA
From Guidelines to Practice: Key Updates From 2021 HFSA
0.25 credits
- Ileana L. Piña, MD, MPH, FAHA, FACC
  Peer
- Javed Butler, MD, MBA, MPH
  Peer
- Gregg C. Fonarow, MD
  Peer
- Giuseppe M.C. Rosano, MD, PhD, FESC, FHFA
  Peer
3
CME/CE
Demystifying Continued Pharmacologic Therapy in HFrEF – Pivotal Opportunities to Improve Patient Outcomes
Demystifying Continued Pharmacologic Therapy in HFrEF – Pivotal Opportunities to Improve Patient Outcomes
1.50 credits
- Javed Butler, MD, MBA, MPH
  Peer
- Giuseppe M.C. Rosano, MD, PhD, FESC, FHFA
  Peer
- Deepak L. Bhatt, MD, MPH, FACC, FAHA, FSCAI, FESC
  Peer
7
CME/CE
A New Normal? COVID-19 and HF in Clinical Trials
A New Normal? COVID-19 and HF in Clinical Trials
0.25 credits
- Robert J. Mentz, MD, FHFSA, FACC, FAHA
  Peer
- Peter van der Meer, MD, PhD
  Peer
5
CME/CE
A Clinical Guide to the Role of Iron in HF Pathophysiology
A Clinical Guide to the Role of Iron in HF Pathophysiology
0.25 credits
- Javed Butler, MD, MBA, MPH
  Peer
- Giuseppe M.C. Rosano, MD, PhD, FESC, FHFA
  Peer
3
CME/CE
Optimizing RAASi Therapy in Patients with Hyperkalemia: The Role of Potassium Binders
Optimizing RAASi Therapy in Patients with Hyperkalemia: The Role of Potassium Binders
0.25 credits
- Gregory Lewis, MD
  Peer
- Michael Böhm, MD, FESC
  Peer
- Josep Comin-Colet, MD, PhD
  Peer
6
CME/CE
Die klinische Bedeutung der Behandlung von Eisenmangel laut AFFIRM-AHF
Die klinische Bedeutung der Behandlung von Eisenmangel laut AFFIRM-AHF
0.25 credits
- Ewa A. Jankowska, MD, PhD, FESC
  Peer
8
Global Heart Failure Academy
AFFIRM-AHF: Key Takeaways
AFFIRM-AHF: Key Takeaways
- Stefan D. Anker, MD, PhD
  Peer
- Javed Butler, MD, MBA, MPH
  Peer
- Ewa A. Jankowska, MD, PhD, FESC
  Peer
- Josep Comin-Colet, MD, PhD
  Peer
11
Global Heart Failure Academy
Late-breaking First Response on AFFIRM-AHF
Late-breaking First Response on AFFIRM-AHF
- Mikhail Kosiborod, MD
  Peer
6
Global Heart Failure Academy
CARE HK in HF: Designing a Real-world Study to Identify Barriers to Guideline-directed RAASi Therapy
CARE HK in HF: Designing a Real-world Study to Identify Barriers to Guideline-directed RAASi Therapy

Segment Chapters

Playlist:

Recommended

Webpack App